KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Change in Accured Expenses (2018 - 2025)

Progyny (PGNY) has disclosed Change in Accured Expenses for 8 consecutive years, with -$12.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses changed N/A to -$12.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.9 million, a N/A change, with the full-year FY2025 number at $417000.0, down 95.8% from a year prior.
  • Change in Accured Expenses was -$12.7 million for Q4 2025 at Progyny, down from $17.5 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $17.5 million in Q1 2025 to a low of -$12.7 million in Q4 2025.
  • A 5-year average of $2.6 million and a median of $2.1 million in 2023 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: plummeted 558.0% in 2021, then surged 7240.32% in 2022.
  • Progyny's Change in Accured Expenses stood at -$10.9 million in 2021, then skyrocketed by 70.81% to -$3.2 million in 2022, then skyrocketed by 56.55% to -$1.4 million in 2023, then soared by 408.89% to $4.3 million in 2024, then tumbled by 397.64% to -$12.7 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's Change in Accured Expenses are -$12.7 million (Q4 2025), $17.5 million (Q1 2025), and $4.3 million (Q3 2024).